Condition

Merosin Deficient Congenital Muscular Dystrophy clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Merosin Deficient Congenital Muscular Dystrophy clinical trials that are recruiting, at sites in 3 countries (most in Italy (1), France (1), Spain (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Merosin Deficient Congenital Muscular Dystrophy clinical trials

StudyPhaseWhereStatusRegistered
Natural history and biomarker mapping for LAMA2-related dystrophy — Milan Recruiting Aug 15, 2025
Natural history study of LAMA2 muscular dystrophy in children — Barcelona, Barcelona Recruiting Apr 11, 2025
Observing the progression of LAMA2-related muscular dystrophies in children — Garches and 3 other locations Recruiting Apr 9, 2024

All recruiting trials (3)

Related topics

LAMA2-MD (Merosin Deficient Congenital Muscular Dystrophy, MDC1A)Merosin Deficient CMD (Full or Partial)Cohort StudiesMuscular Dystrophies

Quick answers

How many Merosin Deficient Congenital Muscular Dystrophy clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in Italy (1 trial), France (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.